Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
BMC Immunol
Key highlights Ozempic (semaglutide) is an FDA-approved GLP-1 medication for type 2 diabetes management, cardiovascular risk reduction, and reducing the risk of worsening kidney disease in patients with chronic kidney disease and type 2 diabetes
is developing an antisense oligonucleotide drug, ATL1103 (now atesidorsen)
Packaging been damaged for a duplicate product
Data availability Requests for data and materials should be addressed to the corresponding author
Clinical trials for semaglutide found that over 40% of participants reported nausea, and gastrointestinal side effects were the leading reason people reduced their dose or stopped altogether
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
